Sean X. Luo

Medicine · Health Sciences

13h-index673citations43works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Opioid Use Disorder Treatment(14), Substance Abuse Treatment and Outcomes(11), Attention Deficit Hyperactivity Disorder(6), Smoking Behavior and Cessation(4), HIV, Drug Use, Sexual Risk(4)

Publications42 total

Carl Schmitt’s Critique of Liberal Political Theory and Its Contemporary Relevance
Advances in Education Humanities and Social Science Research·2025Open Access
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment
JAMA Psychiatry·2023· 17 citedOpen Access
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
Drug and Alcohol Dependence·2023· 5 citedOpen Access
Clinical effect of endovascular repair of complex aortic lesions using optimized Octopus surgery
Frontiers in Bioengineering and Biotechnology·2023Open Access
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder
American Journal of Psychiatry·2023· 14 citedOpen Access
Immune checkpoint inhibitors related respiratory disorders in patients with lung cancer: A meta-analysis of randomized controlled trials
Frontiers in Immunology·2023· 12 citedOpen Access
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
Addiction Science & Clinical Practice·2023· 15 citedOpen Access
Rudolph et al. Respond to “Mathematization of Epidemiology”
American Journal of Epidemiology·2023Open Access
Treatment of abdominal aortic pseudoaneurysm caused by brucellosis with endovascular aneurysm repair
Frontiers in Bioengineering and Biotechnology·2023· 1 citedOpen Access
Optimally Choosing Medication Type for Patients With Opioid Use Disorder
American Journal of Epidemiology·2022· 8 citedOpen Access
Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
Drug and Alcohol Dependence Reports·2022· 15 citedOpen Access
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder
Drug and Alcohol Dependence·2022· 12 citedOpen Access
Under-representation of key demographic groups in opioid use disorder trials
Drug and Alcohol Dependence Reports·2022· 13 citedOpen Access
Optimizing opioid use disorder treatment with naltrexone or buprenorphine
Drug and Alcohol Dependence·2021· 10 citedOpen Access
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl
American Journal on Addictions·2021· 23 citedOpen Access
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder
The American Journal of Drug and Alcohol Abuse·2021· 10 cited
Medication use and physical assaults in the psychiatric emergency room
2021Open Access
Individual level prediction of emerging suicide events in the pharmacologic treatment of bipolar disorder
2021Open Access
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables
Addiction·2020· 9 cited
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19
Journal of Addiction Medicine·2020· 19 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Edward V. Nunes(16), Frances R. Levin(9), John Rotrosen(9), Mei‐Chen Hu(8), Kara E. Rudolph(7), Andrew J. Saxon(5), Iván Díaz(5), John J. Mariani(4), Daniel J. Feaster(4), Raymond R. Balise(4), Lirio S. Covey(4), Theresa Winhusen(4), Timothy K. Brennan(4), Justine W. Welsh(4), Amy L. Mahony(3), Nasir H. Naqvi(3), Christina Brezing(3), Gabriel Odom(3), Laura A. Brandt(3), Felipe Castillo(3)